Harris Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-506,968
Closed -$17.4M 132
2018
Q1
$17.4M Sell
506,968
-249,910
-33% -$8.78M 0.03% 108
2017
Q4
$24.8M Sell
756,878
-18,766
-2% -$647K 0.04% 103
2017
Q3
$25.9M Hold
775,644
0.04% 105
2017
Q2
$27.6M Sell
775,644
-788,876
-50% -$26.6M 0.05% 104
2017
Q1
$48.1M Buy
+1,564,520
New +$48.2M 0.09% 97

Other funds holding QGEN

Harris Associates's QGEN Position: Q2 2018 in Review

Harris Associates sold out of Qiagen (QGEN) in Q2 2018, closing a stake of 506,968 shares — an estimated $17.4M sold.

Harris Associates first reported a position in QGEN in Q1 2017 and held it in 5 quarters. The position peaked at $48.1M in Q1 2017. 231 funds tracked by Wall St. Rank hold QGEN as of Q2 2018.

  • Harris Associates reported no remaining Qiagen position as of Q2 2018 after selling out during the quarter.
  • Harris Associates sold 506,968 Qiagen shares in Q2 2018, an estimated $17.4M.
  • Harris Associates first reported a position in Qiagen in Q1 2017 and held it in 5 quarters.
  • Harris Associates's Qiagen position peaked at $48.1M in Q1 2017.
  • 231 funds tracked by Wall St. Rank held Qiagen as of Q2 2018.

Based on Harris Associates's 13F filing for Q2 2018, filed 14 Aug 2018.